Galan Lithium Ltd reports developments tied to its lithium exploration and development business, including the Hombre Muerto West and Candelas lithium brine projects on the Hombre Muerto Salar in Argentina. Company updates center on HMW Phase 1 construction, nanofiltration and evaporation-pond infrastructure, planned lithium chloride concentrate production, and staged capacity growth.
Recurring news also covers capital-structure disclosures, shareholder voting matters, governance appointments, operating and financial results, and quarterly activity reporting. Additional updates address financing for project development, regulatory approvals and community commitments, and exploration tenure associated with the company’s lithium portfolio.
Galan Lithium (GLNLF) expects first lithium chloride concentrate sales from Hombre Muerto West in Argentina in Q4 CY2026 as ramp-up continues. The company targets initial throughput of 4,000 tonnes per year of lithium carbonate equivalent (LCE) in the first half of 2027. Earthworks have begun to expand capacity to 5,200 tonnes per year, with higher volumes expected in the second half of 2027; no nanofiltration plant modifications are required.
Severe winter weather caused minor operating suspensions. Galan holds construction permits for Phase 2 capacity of 21,000 tonnes per year of LCE. At 30 September 2026, cash was A$25 million, with no debt drawn. A government-co-funded gravity survey at Greenbushes South is scheduled for November 2026, with processed results expected in Q1 2027. Daniel Jimenez succeeded Richard Homsany as non-executive chairman on 1 October 2026.
Galan Lithium (GLNLF) reported continued ramp-up at its Hombre Muerto West Phase 1 lithium chloride operation in Argentina. The nanofiltration plant is keeping pace with current site evaporation rates. It has recorded more than three months of data showing at least 98% sulphate rejection.
Galan expects first lithium chloride concentrate sales for delivery in Q4 2026 and initial throughput of 4ktpa lithium carbonate equivalent (LCE) in the first half of 2027. Impurity separation and recoveries to date support upgrading the concentrate toward a targeted 6% lithium content.
Earthworks have begun for an expansion of Phase 1 to 5.2ktpa. Galan expects the higher production volumes in the second half of 2027.
Galan Lithium (OTC:GLNLF, ASX:GLN) released an updated investor presentation outlining its transition from developer to producer after completing wet commissioning at the HMW project and producing first processed lithium chloride in the June 2026 quarter. The company targets first lithium chloride concentrate sales in H2 2026, highlights a 9.5Mt contained LCE resource ranked among the top 10 globally, profiles HMW in the first quartile of the global lithium cost curve, and notes that its shares trade at a discount to ASX-listed lithium peers on an EV/contained LCE basis. The full presentation is available via the ASX Company Announcements Platform.
Galan Lithium (OTC:GLNLF) reported its June 2026 quarter marked its transition from developer to producer at the 100% owned Hombre Muerto West (HMW) project in Argentina, completing Phase 1 construction, wet commissioning and producing first processed lithium chloride.
The company is ramping up operations toward stabilised production at an annualised rate of 4 ktpa LCE in 2026, targeting first lithium chloride concentrate and product sales in H2 2026. Galan has built circa 10,000 t LCE brine inventory in evaporation ponds to support the ramp-up. Phase 1 expansion to 5.2 ktpa LCE remains on track, with new pond construction due to start in the September 2026 quarter and capacity uplift targeted for H1 2027. Galan ended the quarter with A$35.5 million cash and no debt, holds permits for a Phase 2 expansion to 21 ktpa LCE, and plans staged growth up to 60 ktpa LCE.
Galan Lithium (OTC:GLNLF) has completed wet plant commissioning and produced its first processed lithium chloride brine at the 100%-owned Hombre Muerto West (HMW) project in Catamarca, Argentina.
The company is optimising operations toward 4 ktpa LCE Phase 1 capacity, targeting LiCl concentrate sales in H2 2026 and a Phase 1 expansion to 5.2 ktpa LCE by H1 2027.
Galan Lithium (ASX:GLN, OTC:GLNLF) has requested a voluntary suspension of its securities effective immediately. The suspension is pending an operational update on commissioning of Phase 1 production at the Hombre Muerto West project.
The company asks that the suspension last until it releases this update or until trading commences on Thursday, 28 May 2026, whichever occurs first. Galan Lithium states it is not aware of any reason the suspension should not be granted.
Galan Lithium (GLNLF) completed Phase 1 construction at Hombre Muerto West, finished electrical and mechanical testing, and will begin wet commissioning. A A$40.0m institutional placement at A$0.41/share was completed to fund a Phase 1 expansion from 4 ktpa LCE to 5.2 ktpa LCE. Circa 10,000 t LCE brine inventory is ready for processing; first lithium chloride concentrate targeted in H1 2026 and first shipment H2 2026. Closing cash A$40.7m with no debt. Board strengthened with a new non-executive director and company secretary. Phase 2 permits (21 ktpa LCE) are held for staged growth.
Galan Lithium (ticker GLNLF) reports Phase 1 construction at Hombre Muerto West (HMW) is complete and the project has moved into testing and commissioning. Initial lithium chloride concentrate production is targeted H1 2026 with first shipment H2 2026, and steady production planned at 4,000 tpa LCE.
The company holds circa 10,000 t LCE brine inventory in evaporation ponds and will commence works to expand to 5,200 tpa LCE, targeting uplift in H1 2027; Phase 2 permits cover 21 ktpa with staged growth to 60 ktpa.
Galan Lithium (GLNLF) reports Phase 1 construction at Hombre Muerto West is approximately 92% complete, with nanofiltration plant assembly progressing and >25 personnel mobilised on site.
The project will move to testing and commissioning in the short term, with first processed brine targeted in early Q2 2026 and first lithium chloride concentrate expected in H1 2026. Phase 1 is designed for a 5,200 tpa LCE rate and has substantial brine inventory in evaporation ponds to support initial processing.
Galan Lithium (OTC:GLNLF) reports the nanofiltration plant for Phase 1 was delivered to the Hombre Muerto West (HMW) site and on-site assembly has begun. Phase 1 construction is ~85% complete with sylvinite evaporation ponds finished.
The company holds about 9,500 t LCE of brine inventory in ponds. First processed brine is targeted for early Q2 2026 and first lithium chloride concentrate is targeted in H1 2026. Phase 1 expanded production rate aims for 5,200 tpa LCE.